Search results for "AEM"

showing 10 items of 1006 documents

Lonoctocog alfa (rVIII-SingleChain) for the treatment of haemophilia A

2017

Introduction: The administration of factor VIII (FVIII) concentrates on-demand or on long-term prophylaxis is the effective and safe standard of care of patients with hemophilia A (HA). Development of neutralizing antibodies against exogenous FVIII and the short half-life of the current available products remain major challenges. There is currently a great interest towards newer FVIII products with the goal of reducing the inhibitor risk and increasing the half-life. Area covered: In this review, the authors describe the efficacy and safety of rVIII-SingleChain (Lonoctocog alfa), the first and only single chain recombinant FVIII (rFVIII) molecule developed for the prevention and treatment o…

congenital hereditary and neonatal diseases and abnormalitiesPediatricsmedicine.medical_specialtyHaemophiliaStandard of caresingle-chainHaemophilia AClinical BiochemistrySingle chain030204 cardiovascular system & hematologyHaemophiliaHemophilia A03 medical and health sciences0302 clinical medicineLONOCTOCOG ALFAhemic and lymphatic diseasesDrug DiscoverymedicineHumansPharmacologyClinical Trials as TopicFactor VIIIbusiness.industryCoagulantsDrug Discovery3003 Pharmaceutical ScienceRecombinant Proteinmedicine.diseaseRecombinant ProteinsCoagulantbusiness030215 immunologyHalf-LifeHuman
researchProduct

A systematic overview of the first pasteurised VWF/FVIII medicinal product, Haemate P/Humate -P: history and clinical performance

2008

Patients with von Willebrand disease (VWD) and haemophilia A (HA) lack, to varying degrees, the von Willebrand factor (VWF) and coagulation factor VIII (FVIII) that are critical for normal haemostasis. These conditions in turn make patients prone to uncontrolled bleeding. Historically, patients with severe forms of VWD or HA were crippled before adulthood and their life expectancy was significantly reduced. Over the past decades, specific coagulation factor replacement therapies including Haemate P, have been developed to help patients achieve and maintain normal haemostasis. Haemate P is a human, plasma-derived VWF/FVIII medicinal product, which was first licensed in Germany in 1981 for th…

congenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyHaemophilia AHemophilia AHaemophiliaHaemate P; Humate-P; von Willebrand disease; von Willebrand factor; haemophilia; factor VIIIVon Willebrand factorhemic and lymphatic diseasesInternal medicinevon Willebrand FactormedicineVon Willebrand diseaseHumansDosingDesmopressinHematologybiologybusiness.industryHematologyGeneral Medicinemedicine.diseasevon Willebrand DiseasesCoagulationImmunologybiology.proteinSafetybusinessSettore MED/15 - Malattie del Sanguemedicine.drug
researchProduct

Results of a Prospective, Open-Label Trial to Assess the Efficacy, Safety and Immunogenicity of Wilate® in Children Under 6 Years of Age with Inherit…

2011

Abstract Abstract 3330 Introduction: Wilate® is a new-generation plasma-derived concentrate of von Willebrand factor (VWF) and factor VIII (FVIII) developed for treatment of patients with von Willebrand disease (VWD) and haemophilia A. The objective of this study was to assess efficacy, safety and immunogenicity of Wilate in children below 6 years of age with inherited VWD. Methods: The prospective, multi-centre trial included patients with inherited VWD of any type below 6 years of age with insufficient response to DDAVP. Any clinical event requiring VWF/FVIII concentrate treatment within 1 year was treated with Wilate. Efficacy was recorded by using a 4-point VRS and in vivo recovery of F…

congenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyPediatricsbiologybusiness.operationbusiness.industryImmunogenicityImmunologyCell BiologyHematologyHaemophiliamedicine.diseaseOctapharmaBiochemistryVon Willebrand factorTolerabilityhemic and lymphatic diseasesInternal medicinemedicinebiology.proteinVon Willebrand diseaseDosingbusinessAdverse effectBlood
researchProduct

Ocena działania preparatu Solcoseryl u chorych po rekonstrukcjach naczyń z powodu krytycznego niedokrwienia kończyn dolnych

2002

Wstęp: Celem pracy była ocena skuteczności leczenia stosowanym dożylnie preparatem Solcoseryl u chorych po rekonstrukcjach naczyń z powodu krytycznego niedokrwienia kończyn dolnych i wyczerpaniu wszystkich możliwości dalszego leczenia chirurgicznego. Założono, że podawanie preparatu Solcoseryl chorym po udanej rekonstrukcji naczyniowej powoduje szybkie ustąpienie bólu i obrzęku, przyspieszenie gojenia się owrzodzeń i demarkację martwicy. Materiał i metody: Do badanej grupy zakwalifikowano 60 chorych leczonych operacyjnie z powodu krytycznego niedokrwienia kończyn dolnych. Średnia wieku wynosiła odpowiednio dla dwóch grup 59,2 i 57,8 roku. Badanie przeprowadzono metodą podwójnie ślepej próby…

critical limb ischaemiavascular reconstructionrekonstrukcje naczyńsolcoserylkrytyczne niedokrwienie kończyn dolnychChirurgia Polska
researchProduct

Drug-induced infiltrative lung disease

2009

International audience; Because the lung manifestations of drugs may be highly variable, a high index of suspicion is required. Both current and past drug intake should be carefully evaluated in any patient with infiltrative lung disease. Drug-induced infiltrative lung disease may manifest as variable clinical radiological patterns, including subacute or chronic interstitial pneumonia, pulmonary fibrosis, eosinophilic pneumonia (presenting as Loffler syndrome, or chronic or acute eosinophilic pneumonia), organising pneumonia, diffuse alveolar haemorrhage, acute respiratory distress syndrome, pulmonary oedema, lipoid pneumonia, alveolar proteinosis or sarcoidosis. A variety of drugs have bee…

drug-inducedinterstitial lung disease[SDV] Life Sciences [q-bio]03 medical and health sciences0302 clinical medicinepulmonary fibrosis030220 oncology & carcinogenesis[SDV]Life Sciences [q-bio]eosinophil030212 general & internal medicineorganising pneumonia3. Good healthalveolar haemorrhage
researchProduct

A health promotion intervention to improve lifestyle choices and health outcomes in people with psychosis: a research programme including the IMPaCT …

2020

Background People with psychotic disorders have reduced life expectancy largely because of physical health problems, especially cardiovascular disease, that are complicated by the use of tobacco and cannabis. Objectives We set out to (1) chart lifestyle and substance use choices and the emergence of cardiometabolic risk from the earliest presentation with psychosis, (2) develop a pragmatic health promotion intervention integrated within the clinical teams to improve the lifestyle choices and health outcomes of people with psychosis and (3) evaluate the clinical effectiveness and cost-effectiveness of that health promotion intervention. Design We performed a longitudinal cohort study of peo…

dysglycaemiamedicine.medical_specialtyhealth promotionMotivational interviewingmotivational interviewinglaw.invention03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Randomized controlled triallawIntervention (counseling)medicinepsychosis030212 general & internal medicinerctFirst episodelifestyle choicesbusiness.industrylcsh:Public aspects of medicineweightlcsh:RA1-1270waist circumferenceMental health030227 psychiatryHealth promotionquality of lifeFamily medicineLife expectancybusinessphysical healthmental healthProgramme Grants for Applied Research
researchProduct

Design and rationale of a nationwide screening analysis from the LIPIDOGRAM2015 and LIPIDOGEN2015 studies.

2022

IntroductionCardiovascular disease (CVD) is a major cause of morbidity and mortality throughout the world. The LIPIDOGRAM2015 study was performed to estimate the prevalence of risk factors for atherosclerotic diseases as well as cardiovascular and related disorders in the primary care setting in Poland. The LIPIDOGEN2015 sub-study was designed to include a random cohort of patients in order to analyse parameters related to lipid metabolism, oxidative stress, inflammatory responses, autoimmune disorders, and gene variants that confer susceptibility to cardiometabolic and atherosclerotic diseases.Material and methodsThe recruitment was carried out by 438 primary care physicians in Poland. The…

dyslipidaemiabusiness.industryGeneral Medicinemedicine.diseaseBioinformaticsmedicine.disease_causeScreening analysiscardiovascular diseasesinflammationmedicineoxidative stressatherosclerosisbusinesscardiometabolic diseasesgenesDyslipidemiaOxidative stressArchives of medical science : AMS
researchProduct

The determination of haemoglobin as cyanhaemiglobin or as alkaline haematin D-575. Comparison of method-related errors.

1989

In order to compare the accuracy of haemoglobin (Hb) determination methods, the commonly used cyanhaemiglobin (HiCN) method and the recently developed alkaline haematin D-575 (AHD) method (R. Zander, W. Lang & H. U. Wolf (1984) Clin. Chim. Acta 136, 83-93; H. U. Wolf, W. Lang & R. Zander (1984) Clin. Chim. Acta 136, 95-104) were tested with respect to method-related errors such as plasma, cell, and Hb errors. Both methods yield a series of more or less significant errors which generally lead to an overestimation of the Hb concentration in the order of 1%. However, in all three cases of plasma errors, i.e. normal plasma error, plasma error in lipaemic blood, and plasma error in bilirubinaemi…

educationBiochemistry (medical)Clinical BiochemistryErythrocyte MembraneAnalytical chemistryHyperlipidemiasGeneral MedicineBiologyHaematinRed blood cellchemistry.chemical_compoundHemoglobinsmedicine.anatomical_structurechemistryCarboxyhemoglobinPredictive Value of TestsBlood plasmamedicineLeukocytesDetermination methodsHumansHemoglobinFetal HemoglobinHyperbilirubinemiaJournal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie
researchProduct

Continental-scale patterns of pathogen prevalence: a case study on the corncrake

2014

Pathogen infections can represent a substantial threat to wild populations, especially those already limited in size. To determine how much variation in the pathogens observed among fragmented populations is caused by ecological factors, one needs to examine systems where host genetic diversity is consistent among the populations, thus controlling for any potentially confounding genetic effects. Here, we report geographic variation in haemosporidian infection among European populations of corncrake. This species now occurs in fragmented populations, but there is little genetic structure and equally high levels of genetic diversity among these populations. We observed a longitudinal gradient…

education.field_of_studyGenetic diversitybirdHost (biology)Ecologyparasite transmissionPopulationMetapopulationOriginal ArticlesBiologycorncrakePopulation densityapproximate Bayesian computationhaemosporidian parasitesEffective population sizeAbundance (ecology)Genetic structureGeneticsavian malariaCrex crexagriculture intensityGeneral Agricultural and Biological ScienceseducationEcology Evolution Behavior and Systematicseffective population size
researchProduct

Genetic and morphological differentiation ofDikerogammarusinvaders and their invasion history in Central Europe

2002

SUMMARY 1. Biological invasions often involve close taxonomic relatives either as native/invader pairs or as invader/invader pairs. Precise identification and differentiation of species is therefore of paramount importance to reconstruct the invasion history. Genetic studies are indispensable in the case of morphologically conservative taxonomic groups. 2. We analysed the Pontocaspian freshwater amphipods Dikerogammarus that have successfully invaded the benthos of large Central European rivers. Taxonomic uncertainties were clarified by phylogenetic analyses of mitochondrial 16S and COI genes. The three-way partitioning of allozyme genotypes in a syntopic population further corroborated the…

education.field_of_studybiologyPopulationZoologyDikerogammarus villosusAquatic ScienceSubspeciesbiology.organism_classificationColonisationDikerogammarus haemobaphesDikerogammarusTaxonomic rankGenetic variabilityeducationFreshwater Biology
researchProduct